UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046808
Receipt number R000053400
Scientific Title A multicenter retrospective observational study for pulmonary resection in pulmonary origometastasis after pancreatectomy
Date of disclosure of the study information 2022/02/02
Last modified on 2024/02/05 15:29:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter retrospective observational study for pulmonary resection in pulmonary origometastasis after pancreatectomy

Acronym

An observational study for pulmonary origometastasis after pancreatectomy

Scientific Title

A multicenter retrospective observational study for pulmonary resection in pulmonary origometastasis after pancreatectomy

Scientific Title:Acronym

JON2106-P

Region

Japan


Condition

Condition

Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare the overall survival in patients with recurrent pulmonary origometastasis of pancreatic cancer received treatment including lung resection and only systemic chemotherapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Started the treatment for pulmonary metastasis before Dec. 31, 2020 in patients received radical resection (R0 or R1) for pancreatic cancer between Jan. 2009 and Dec. 2019.
2) Diagnosed as pancreatic ductal adenocarcinoma in reseced specimen.
3) Received chemotherapy or lung resection for only unilateral recurrent pulmonary metastasis .

Key exclusion criteria

1) Intraductal papillary mucinous carcinoma

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Hidenori
Middle name
Last name Takahashi

Organization

Osaka International Cancer Institute

Division name

Department of Gastroenterological Surgery

Zip code

541-8567

Address

3-1-69 Otemae, Chuo-ku, Osaka, Japan

TEL

+81-6-6945-1181

Email

htakahashi@oici.jp


Public contact

Name of contact person

1st name Ryoji
Middle name
Last name Takada

Organization

Osaka International Cancer Institute

Division name

Department of Hepatobiliary and Pancreatic Oncology

Zip code

541-8567

Address

3-1-69 Otemae, Chuo-ku, Osaka, Japan

TEL

+81-6-6945-1181

Homepage URL


Email

ryoji.takada@oici.jp


Sponsor or person

Institute

Japan Oncology Network in Hepatobiliary and Pancreas

Institute

Department

Personal name



Funding Source

Organization

Japan Oncology Network in Hepatobiliary and Pancreas

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Osaka International Cancer Institute

Address

3-1-69 Otemae, Chuo-ku, Osaka, Japan

Tel

+81-6-6945-1181

Email

rinri01@opho.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター中央病院(東京都)
石川県立中央病院(石川県)
神奈川県立がんセンター(神奈川県)
大阪市立総合医療センター(大阪府)
聖隷浜松病院(静岡県)
兵庫県立がんセンター(兵庫県)
山口大学医学部附属病院(山口県)
金沢大学医学部付属病院(石川県)
高知医療センター(高知県)
新潟県立がんセンター新潟病院(新潟県)
北海道大学病院(北海道)
杏林大学医学部付属病院(東京都)
京都大学医学部付属病院(京都府)
山形大学医学部付属病院(山形県)
慶應義塾大学医学部付属病院(東京都)
聖マリアンナ医科大学病院(神奈川都)
大阪医療センター(大阪府)
香川大学医学部附属病院(香川県)
埼玉県立がんセンター(埼玉県)
国立国際医療研究センター病院(東京都)
大阪大学医学部付属病院(大阪府)
四国がんセンター(愛媛県)
宮崎大学医学部附属病院(宮崎県)
東北大学病院(宮城県)
千葉大学医学部附属病院(千葉県)
東京医科大学病院(東京都)
東京女子医科大学病院(東京都)
国立がん研究センター東病院(千葉県)
神戸大学医学部付属病院(兵庫県)
浜松医科大学医学部付属病院(静岡県)
静岡県立総合病院(静岡県)


Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 11 Month 17 Day

Date of IRB

2022 Year 01 Month 26 Day

Anticipated trial start date

2022 Year 02 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2023 Year 09 Month 30 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

None


Management information

Registered date

2022 Year 02 Month 02 Day

Last modified on

2024 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053400